EUVIMEDEUVIMED entdecken
Open Access

SLC13A2-transported citrate remodels transcriptional regulation through protein acetylation to suppress tumor growth

Mengyao Qin iD, Longcheng Shang iD, Hao Chen iD, Li Shi iD, Chan Liu iD, Ming Ding iD, Dandan He iD, Chang Shao iD, Shengtao Yuan iD, Hong Yu iD, Haiping Hao iD, Yong Ma iD und 1 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aec4368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Mengyao Qin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Gene Expression Regulation, Neoplastic, Citric Acid, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, China Pharmaceutical University, Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic reprogramming is a hallmark of cancer, while tricarboxylic acid cycle is increasingly recognized as a multifaceted hub driving tumor metabolism and progression. Integrated analysis of solute carrier (SLC) transporters revealed consistent down-regulation of SLC13A2 in hepatocellular carcinoma (HCC) cells and liver tissues from human patients and mouse models. Adeno-associated virus–mediated liver-specific knockout or overexpression of SLC13A2 (SLC13A2-OE) promoted or ameliorated HCC progression, indicating its protective role. SLC13A2 inhibited HCC proliferation by decreasing mitochondrial function via suppressed glycolysis, respiration, and adenosine 5′-triphosphate production. Flux analysis showed that SLC13A2 imported citrate to generate acetyl–coenzyme A for pyruvate kinase isozyme type M2 acetylation, triggering its degradation. Reduced pyruvate kinase activity limited pyruvate supply, impairing amino acid synthesis and nucleotide metabolism. Moreover, SLC13A2-imported citrate induced intracellular protein acetylation, particularly histone proteins, which provided an epigenetic basis for transcriptional regulation and contributed to tumor suppression. Thus, SLC13A2 perturbs metabolic and transcriptional programs to suppress tumor growth, highlighting potential drug targets for HCC therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsGene Expression Regulation, NeoplasticCitric AcidCarcinoma, HepatocellularTranscription, GeneticSymportersHumansAcetylationAnimalsMiceCell ProliferationMetabolic ReprogrammingCell Line, Tumor

Substanzen

Citric AcidSymporters

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.
  • Department of General Surgery, Nanjing First Hospital, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.
  • Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.
  • Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, Jiangsu 210009, China.
  • Department of Pathology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu 225300, China.

ORCID-Profile: Mengyao Qin, Longcheng Shang, Hao Chen, Li Shi, Chan Liu, Ming Ding, Dandan He, Chang Shao, Shengtao Yuan, Hong Yu, Haiping Hao, Yong Ma, Jing Xiong

Förderung

  • National Natural Science Foundation of China
  • China Pharmaceutical University
  • Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars

Zitieren

APA

Qin, M., Shang, L., Chen, H., Shi, L., Liu, C., Ding, M., He, D., Shao, C., Yuan, S., Yu, H., Hao, H., Ma, Y., & Xiong, J. (2026). SLC13A2-transported citrate remodels transcriptional regulation through protein acetylation to suppress tumor growth. Science Advances. https://doi.org/10.1126/sciadv.aec4368

Vancouver

Qin M, Shang L, Chen H, Shi L, Liu C, Ding M, et al. SLC13A2-transported citrate remodels transcriptional regulation through protein acetylation to suppress tumor growth. Science Advances. 2026. doi:10.1126/sciadv.aec4368

BibTeX
@article{Qin2026,
  author = {Qin, Mengyao and Shang, Longcheng and Chen, Hao and Shi, Li and Liu, Chan and Ding, Ming and He, Dandan and Shao, Chang and Yuan, Shengtao and Yu, Hong and Hao, Haiping and Ma, Yong and Xiong, Jing},
  title = {SLC13A2-transported citrate remodels transcriptional regulation through protein acetylation to suppress tumor growth},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aec4368}
}
Kostenlos starten →